For citations:
Kalinin A.E., Avdyukhin I.G., Nered S.N., Besova N.S., Tryakin A.A., Artamonova E.V., Titova T.A., Obarevich E.S., Ignatova E.O., Kozlov N.A., Rossomakhina O.V., Shishkina N.A., Kolobanova E.S., Malikhova O.A., Abgaryan M.G., Nikulin M.P., Arkhiri P.P., Vashakmadze L.A., Peregorodiev I.N., Suleimanov E.A., Stilidi I.S. Efficacy of perioperative FOLFIRINOX chemotherapy versus FLOT chemotherapy in patients with resectable adenocarcinoma of the stomach or gastroesophageal junction (SIEWERT types II–III, cT4aN0M0, T1–4cN+ cM0): preliminary results of the study. Malignant tumours. 2023;13(4):7-17. (In Russ.) https://doi.org/10.18027/2224-5057-2023-13-4-7-17
Email this article 